Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126133973 | 12613397 | 3 | F | 201606 | 20160915 | 20160802 | 20160926 | EXP | GB-ACCORD-042165 | ACCORD | 69.00 | YR | E | F | Y | 0.00000 | 20160926 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126133973 | 12613397 | 1 | PS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 1008 MG, CYCLE 1/6, BY A PAXMAN SCALP COOLER | 40743 | 1008 | MG | /cycle | |||||||
| 126133973 | 12613397 | 2 | SS | Ondansetron Accord | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 206846 | 8 | MG | /cycle | ||||||||
| 126133973 | 12613397 | 3 | SS | EPIRUBICIN | EPIRUBICIN | 1 | Intravenous (not otherwise specified) | 126 MG, CYCLE 1/6, BY A PAXMAN SCALP COOLER | 882 | MG | 2147483647 | 126 | MG | /cycle | |||||
| 126133973 | 12613397 | 4 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 11811 | /cycle | |||||||||||
| 126133973 | 12613397 | 5 | SS | EMEND | APREPITANT | 1 | Oral | 125 MG | 0 | 125 | MG | /cycle | |||||||
| 126133973 | 12613397 | 6 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, CYCLE 1/6, BY A PAXMAN SCALP COOLER | 0 | 6 | MG | /cycle | |||||||
| 126133973 | 12613397 | 7 | SS | Cyclophosphamide Sandoz | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 0.9 MG, CYCLE 1/6, BY A PAXMAN SCALP COOLER | 6.3 | MG | 0 | .9 | MG | INJECTION | /cycle | ||||
| 126133973 | 12613397 | 8 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 0 | 8 | MG | /cycle |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126133973 | 12613397 | 1 | Breast cancer |
| 126133973 | 12613397 | 2 | Product used for unknown indication |
| 126133973 | 12613397 | 3 | Breast cancer |
| 126133973 | 12613397 | 4 | Product used for unknown indication |
| 126133973 | 12613397 | 5 | Product used for unknown indication |
| 126133973 | 12613397 | 6 | Breast cancer |
| 126133973 | 12613397 | 7 | Product used for unknown indication |
| 126133973 | 12613397 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126133973 | 12613397 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126133973 | 12613397 | Alopecia | |
| 126133973 | 12613397 | Condition aggravated | |
| 126133973 | 12613397 | Diarrhoea | |
| 126133973 | 12613397 | Ear pain | |
| 126133973 | 12613397 | Eating disorder | |
| 126133973 | 12613397 | Fatigue | |
| 126133973 | 12613397 | Feeling abnormal | |
| 126133973 | 12613397 | Glossodynia | |
| 126133973 | 12613397 | Headache | |
| 126133973 | 12613397 | Hypophagia | |
| 126133973 | 12613397 | Intercepted medication error | |
| 126133973 | 12613397 | Lethargy | |
| 126133973 | 12613397 | Lower respiratory tract infection | |
| 126133973 | 12613397 | Nausea | |
| 126133973 | 12613397 | Odynophagia | |
| 126133973 | 12613397 | Oral pain | |
| 126133973 | 12613397 | Pharyngeal erythema | |
| 126133973 | 12613397 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126133973 | 12613397 | 1 | 20160608 | 0 | ||
| 126133973 | 12613397 | 3 | 20160608 | 0 | ||
| 126133973 | 12613397 | 6 | 20160608 | 0 | ||
| 126133973 | 12613397 | 7 | 20160608 | 0 |